Pleural effusion in chronic myelomonocytic leukemia

Acta Haematologica

Volumn 99, Issue 1, 1998, Pages 34-37

  Bourantas, K L ^a,b   Tsiara, S ^a   Panteli, A ^a   Milionis, C ^a   Christou, L ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b NONE   (Greece)

Author keywords

Chronic myelomonocytic leukemia; Pleural effusion

Indexed keywords

PREDNISOLONE;

ADULT; AGED; ARTICLE; CANCER INVASION; CASE REPORT; CHRONIC MYELOMONOCYTIC LEUKEMIA; DISEASE COURSE; FEMALE; HUMAN; LYMPHADENOPATHY; MALE; PLEURA EFFUSION; PRIORITY JOURNAL; SYMPTOM;

AGED; ANTI-INFLAMMATORY AGENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MALE; MIDDLE AGED; PLEURAL EFFUSION; PREDNISOLONE;

EID: 0031985976     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000040713     Document Type: Article

References (17)

1. Bennett JM, Catovsky D, Daniel MT, Flandrin C, Galton DAC, Gralnick HR, Soultan CR: The French-American-British (FAB) Cooperative Group: Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189-199.
2. Tefferi A, Hoagland HC, Therneau TM, Pierre RV: Chronic myelomonocytic leukemia: Natural history and prognostic determinants. Mayo Clin Proc 1989;64:1246-1254.
3. Bourantas K, Christou L, Tsiara S, Galanakis E, Sirou M: Follow-up of eighteen patients with chronic myelomonocytic leukemia. J Exp Clin Cancer Res 1995;14:321-326.
4. Michaux JL, Martial P: Chronic myelomonocytic leukemia (CMML) and myelodysplastic or myeloproliferative syndrome. Leuk Lymphoma 1993;9:35-41.
5. Bubbley C, Come P, MacDougall D, Thurner R, Goldberg J: Pericardial tamponade associated with myeloid metaplasia. Am J Hematol 1983;14:185-188.
6. Shih LY, Lin FC, Kuo TT: Cutaneous and pericardial extramedullary hematopoiesis with cardiac tamponade in chronic myeloid leukemia. Am J Clin Pathol 1988;89:693-697.
7. Mufti GJ, Oscier DG, Hamblin TJ, Nightingale A, Parlow S: Serous effusions in monocytic leukaemias. Br J Haematol 1984;58:547-552.
8. Manoharan A: Malignant pleural effusion in chronic myelomonocytic leukemia. Thorax 1991;46:461-462.
9. Mani S, Duffy TP: Pericardial tamponade in chronic myelomonocytic leukemia. Chest 1994;106:967-970.
10. Enright H, Jacob HS, Vercellotti G, Howe R, Belzer M, Miller W: Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: Response to immunosuppressive therapy. Br J Haematol 1995;91:403-408.
11. Billstrom R, Johansson H, Johansson B, Mitelman F: Immune-mediated complications in patients with myelodysplastic syndromes - Clinical and cytogenetic features. Eur J Haematol 1995;58:42-48.
12. Oscier DG, Worsely A, Hamblin TJ, Mufti GJ: Treatment of chronic myelomonocytic leukemia with low-dose etoposide. Br J Haematol 1989;72:468-471.
13. Malammou-Mitsi VD, Stavridis C, Tsiara S, Bourantas K: Malignant pleural effusion as the initial manifestation in chronic lymphocytic leukemia. J Exp Clin Cancer Res 1996;15/ 2:211-213.
14. Bourantas K, Malamou-Mitsi VD, Christou L, Filippidou S, Drosos AA: Cutaneous vasculitis as the initial manifestation in acute myelomonocytic leukemia. Ann Intern Med 1994; 121:942-944.
15. Butler RC, Thompson JM, Keat AC: Paraneoplastic rheumatic disorders: A review. J R Soc Med 1990;126:61-65.
16. Cox NH, Lawrence CM, Langtry JA, Ive FA: Dermatomyositis. Disease associations and an evaluation of screening investigations for malignancy. Arch Dermatol 1990;126:61-65.
17. Rosen AM, Haines K, Tallman MS, Hakiman D, Ramsey-Goldman R: Rapidly progressive cutaneous vasculitis in a patient with chronic myelomonocytic leukemia. Am J Hematol 1995;50:310-312.